Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Sept. 28, 2020, 8:17 a.m. EDT

Hologic shares gain on authorization of COVID-19 test for asymptomatic people

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Hologic Inc. (HOLX)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Hologic Inc. /zigman2/quotes/201671131/composite HOLX +0.52% were up 3.6% in premarket trading on Monday after the company said it had received emergency use authorization from the Food and Drug Administration for a diagnostic test specifically aimed at people with asymptomatic COVID-19 infections. Hologic said it is the first company to offer a test screening asymptomatic individuals. This test, which is also authorized to test symptomatic people for COVID-19 infections, originally received authorization in March. Hologic's stock is up 23.2% this year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.18% has gained 2.1%.

/zigman2/quotes/201671131/composite
US : U.S.: Nasdaq
$ 67.36
+0.35 +0.52%
Volume: 373,678
Oct. 20, 2020 1:18p
P/E Ratio
27.16
Dividend Yield
N/A
Market Cap
$17.35 billion
Rev. per Employee
$521,033
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,467.22
+40.30 +1.18%
Volume: 1.08B
Oct. 20, 2020 1:19p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.